Macrogenics reported $15.23M in Selling and Administration Expenses for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Abbvie ABBV:US $ 3.07B 228M
Amgen AMGN:US $ 1.38B 130M
AstraZeneca AZN:LN 2.57B 76M
Biogen BIIB:US $ 637.3M 42.3M
Bristol Myers Squibb BMY:US $ 1.88B 215M
Cerulean Pharma CERU:US $ 1.82M 142.69K
Daiichi Sankyo 4568:JP 79.12B 24.69B
Dicerna Pharmaceuticals DRNA:US $ 25.46M 4.79M
Eli Lilly And LLY:US $ 1.69B 109.7M
Epizyme EPZM:US $ 33.89M 2.52M
Genmab GEN:DC 264M 63M
Geron GERN:US $ 7.06M 419K
Gilead Sciences GILD:US $ 1.34B 297M
Immunogen IMGN:US $ 9.73M 481K
Johnson & Johnson JNJ:US $ 6.07B 641M
Karyopharm Therapeutics KPTI:US $ 36.53M 1.12M
Macrogenics MGNX:US $ 15.23M 198K
Merk MRK:US $ 2.25B 376M
Mirati Therapeutics MRTX:US $ 29.61M 1.26M
Pfizer PFE:US $ 2.79B 134M
Puma Biotechnology PBYI:US $ 39.41M 11.17M
Regeneron Pharmaceuticals REGN:US $ 414.7M 9.1M
Seattle Genetics SGEN:US $ 165.13M 5.29M
Xencor XNCR:US $ 8.86M 637K